Healthequity Stock Valuation

HQY
 Stock
  

USD 60.09  2.75  4.80%   

Do you wonder what the value of Healthequity is? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Healthequity, is its stock price multiplied by the total number of shares outstanding, calculating Healthequity's enterprise value requires a different approach. It uses Healthequity's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Free Cash Flow is likely to drop to about 65.6 M in 2022. Enterprise Value is likely to drop to about 4.7 B in 2022.
Healthequity retains a regular Real Value of $62.81 per share. The prevalent price of the firm is $60.09. At this time, the firm appears to be undervalued. Our model calculates the value of Healthequity from evaluating the firm fundamentals such as return on equity of (2.99) %, and Return On Asset of 0.59 % as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage acquiring undervalued assets and dropping overvalued assets since, at some point, asset prices and their ongoing real values will come together.
  
Healthequity Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Healthequity's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Healthequity Most Recent Valuation Data

Price Book
2.61
Enterprise Value
5.9 B
Enterprise Value Ebitda
55.52
Price Sales
6.52
Forward PE
44.84
Enterprise Value Revenue
7.6
Undervalued
Today 60.09
Please note that Healthequity's price fluctuation is very steady at this time. Calculation of the real value of Healthequity is based on 3 months time horizon. Increasing Healthequity's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Healthequity is useful when determining the fair value of the Healthequity stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Healthequity. Since Healthequity is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Healthequity Stock. However, Healthequity's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
62.81
Real Value
65.53
Upside
Estimating the potential upside or downside of Healthequity helps investors to forecast how Healthequity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Healthequity more accurately as focusing exclusively on Healthequity's fundamentals will not take into account other important factors:
Earnings
Estimates (7)
LowProjected EPSHigh
0.770.820.90
Details
Hype
Prediction
LowEstimated ValueHigh
57.3260.0462.76
Details
Naive
Forecast
LowNext ValueHigh
58.0560.7763.49
Details
11 Analysts
Consensus
LowTarget PriceHigh
52.0064.8086.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Healthequity's intrinsic value based on its ongoing forecasts of Healthequity's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Healthequity's closest peers. When choosing an evaluation method for Healthequity, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Healthequity Investments

48.11 Million

Healthequity Valuation Drivers Correlation

Many accounts on the financial statements of Healthequity are highly interrelated and sometimes correlated. Consequently, when conducting Healthequity's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Healthequity
Click cells to compare fundamentals

Healthequity Valuation Trend

Knowing Healthequity's actual value is paramount for traders to make sound investment determinations. Healthequity's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Healthequity's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Healthequity's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Healthequity Market Cap

Healthequity is one of the top stocks in market capitalization category among related companies. Market capitalization of Health Information Services industry is currently estimated at about 1.8 Trillion. Healthequity adds roughly 5.02 Billion in market capitalization claiming only tiny portion of equities under Health Information Services industry.
Capitalization  Total debt  Valuation  Workforce  Revenue

Healthequity Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Healthequity's current stock value. Our valuation model uses many indicators to compare Healthequity value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Healthequity competition to find correlations between indicators driving Healthequity's intrinsic value. More Info.
Healthequity is one of the top stocks in price to book category among related companies. It is one of the top stocks in price to earning category among related companies reporting about  294.51  of Price to Earning per Price to Book. Price to Earnings Ratio is likely to drop to -103.48 in 2022. Earnings Before Interest Taxes and Depreciation Amortization EBITDA is likely to drop to about 95.1 M in 2022. Comparative valuation analysis is a catch-all model that can be used if you cannot value Healthequity by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Healthequity's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Healthequity's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Healthequity's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Healthequity and how it compares across the competition.

About Healthequity Valuation

The equity valuation mechanism determines the current worth of Healthequity on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Healthequity. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Healthequity based exclusively on its fundamental and basic technical indicators. By analyzing Healthequity's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Healthequity's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Healthequity. We calculate exposure to Healthequity's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Healthequity's related companies.
Fiscal Year End
January
Industry
Health Information Services
Concentration
Managed Health Care
Full Time Employees
3.7 K
Service Category
Health Care Providers & Services
Employer Id Number
52-2383166
Last ReportedProjected for 2022
Gross Profit423.7 M457.2 M
Profit Margin(0.06) (0.06) 
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people.

Healthequity Quarterly Enterprise Value

6.01 Billion

Healthequity Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Healthequity does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio2.10
Revenue Growth11.70%
Enterprise Value To Ebitda32.98
Enterprise Value To Revenue7.39

Healthequity Current Valuation Indicators

Valuation refers to the process of determining the present value of Healthequity and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Healthequity we look at many different elements of the entity such as Healthequity's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Healthequity's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Healthequity's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Healthequity, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Healthequity's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Healthequity's worth.
Please check Risk vs Return Analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.1 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.